Cite
HARVARD Citation
Dimopoulos, K. et al. (2019). Expression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myeloma. Leukemia & lymphoma. 60 (1), pp. 180-188. [Online].